Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-26
2011-10-25
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S551000
Reexamination Certificate
active
08044039
ABSTRACT:
The present invention relates to a process for preparing and purifying crystalline quetiapine hemifumarate, which comprises preparing crystalline quetiapine hemifumarate via a crystalline salt, which is not a salt of fumaric acid.
REFERENCES:
patent: 2006/0063927 (2006-03-01), Etlin et al.
patent: 0 282 236 (1988-09-01), None
patent: WO-99/06381 (1999-02-01), None
Ravikumar K. et al: “Quetiapine hemifumarate”, Acta Crystallographica, Section E: Structure Reports Online, XX, XX, vol. E61, No. 10, Sep. 14, 2005, pp. 3245-3248.
Grumann Arne
Huhta Soini
Lusis Viesturs
Rummakko Petteri
Birch & Stewart Kolasch & Birch, LLP
Coleman Brenda
Fermion Oy
LandOfFree
Quetiapine hemifumarate purification by crystallization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quetiapine hemifumarate purification by crystallization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quetiapine hemifumarate purification by crystallization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4279613